文献速递神经核医学

疑似非阿尔茨海默病病理生理(SNAP)与阿尔茨海默病(AD)患者脑代谢模式:[18F]FDG是否为特异性生物标志物?

Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [18F] FDG a specific biomarker in these patients?
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-06-14

本研究比较了SNAP、AD患者与健康对照的脑[18F]FDG摄取模式,利用脑脊液Aβ1-42和tau区分AD与SNAP。结果显示AD较SNAP在右侧额、顶、颞叶广泛低代谢,SNAP较对照仅有限降低,两者代谢模式部分重叠,限制了[18F]FDG PET/CT有效鉴别这两种临床实体。

要点

  • AD较SNAP在右侧额、顶、颞叶广泛低代谢。
  • SNAP较对照仅在相同区域有限降低[18F]FDG摄取。
  • SNAP与AD代谢模式部分重叠,[18F]FDG鉴别效能受限。

核心结论

  • SNAP患者脑[18F]FDG摄取损害较AD轻,但两者代谢模式部分重叠,限制[18F]FDG PET/CT有效鉴别。

研究设计与样本

  • 研究纳入43例新诊断AD患者(女23,男20,符合NINCDS-ADRDA标准)、15例SNAP患者(女12,男3)和34例健康对照(男20,女14)。
  • AD和SNAP受试者接受神经心理测试组套和脑脊液检测,所有受试者注射[18F]FDG后30±5 min行脑PET/CT,采用MATLAB 2018a中的SPM12分析。

主要发现

  • AD较SNAP在涉及右侧额叶、顶叶和颞叶的广泛皮层区域显示显著低代谢。
  • AD较对照在顶叶、边缘叶和额叶皮层[18F]FDG摄取显著降低。
  • SNAP较对照在相同区域[18F]FDG摄取降低更有限。

临床怎么用

  • 解读[18F]FDG PET/CT时需注意SNAP与AD代谢模式存在部分重叠,不能仅凭代谢模式有效鉴别两者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The present study was conducted to compare the pattern of brain [18F] FDG uptake in suspected non-Alzheimer's pathophysiology (SNAP), AD, and healthy controls using 2-deoxy-2-[18F]fluoroglucose ([18F] FDG) positron emission tomography imaging. Cerebrospinal fluid (CSF) biomarkers amyloid-β1-42 peptide (Aβ1-42) and tau were used in order to differentiate AD from SNAP. METHODS: The study included 43 newly diagnosed AD patients (female = 23; male = 20) according to the NINCDS-ADRDA criteria, 15 SNAP patients (female = 12; male =3), and a group of 34 healthy subjects that served as the control group (CG), who were found to be normal at neurological evaluation (male = 20; female = 14). A battery of neuropsychological tests was administrated in AD and SNAP subjects; cerebrospinal fluid assay was conducted in both AD and SNAP as well. Brain PET/CT acquisition was started 30 ± 5 min after [18F] FDG injection in all subjects. SPM12 [statistical parametric mapping] implemented in MATLAB 2018a was used for the analysis of PET scans in this study. RESULTS: As compared to SNAP, AD subjects showed significant hypometabolism in a wide cortical area involving the right frontal, parietal, and temporal lobes. As compared to CG, AD subjects showed a significant reduction in [18F] FDG uptake in the parietal, limbic, and frontal cortex, while a more limited reduction in [18F] FDG uptake in the same areas was found when comparing SNAP to CG. CONCLUSIONS: SNAP subjects show milder impairment of brain [18F] FDG uptake as compared to AD. The partial overlap of the metabolic pattern between SNAP and AD limits the use of [18F] FDG PET/CT in effectively discriminating these clinical entities.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chiaravalloti A, Barbagallo G, Martorana A, et al. Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [18F] FDG a specific biomarker in these patients? Eur J Nucl Med Mol Imaging. 2019. PMID: 31201430. doi:10.1007/s00259-019-04379-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。